Botanical species · safety record

Galanthus woronowii

The EFSA Compendium of Botanicals holds 18 constituent measurements for Galanthus woronowii. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Galanthus woronowii Losinsk.

18Constituent measurements

0Safety records

4Cited sources

0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Alkaloids	Aerial part of plants	Solvent extraction	≥ 0.247 Percent	Volumetric tests	Resolve DOI
Alkaloids	Aerial part of plants	Solvent extraction	≤ 0.499 Percent	Volumetric tests	Resolve DOI
Alkaloids	Bulb / clove	Solvent extraction	≥ 0.25 Percent	Volumetric tests	Resolve DOI
Alkaloids	Bulb / clove	Solvent extraction	≤ 0.412 Percent	Volumetric tests	Resolve DOI
Alkaloids	Live plants	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	Resolve DOI
Galanthamine	Aerial part of plants	Solvent extraction	≥ 0.003 Percent	HPLC-DAD	Resolve DOI
Galanthamine	Aerial part of plants	Solvent extraction	≤ 0.326 Percent	HPLC-DAD	Resolve DOI
Galanthamine	Bulb / clove	Solvent extraction	≥ 0.017 Percent	HPLC-DAD	Resolve DOI
Galanthamine	Bulb / clove	Solvent extraction	≤ 0.506 Percent	HPLC-DAD	Resolve DOI
Galanthine	Bulb / clove	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	Resolve DOI
Lycorine	Aerial part of plants	Solvent extraction	≥ 0.008 Percent	HPLC-DAD	Resolve DOI
Lycorine	Aerial part of plants	Solvent extraction	≤ 0.234 Percent	HPLC-DAD	Resolve DOI
Lycorine	Bulb / clove	Solvent extraction	≥ 0.038 Percent	HPLC-DAD	Resolve DOI
Lycorine	Bulb / clove	Solvent extraction	≤ 0.364 Percent	HPLC-DAD	Resolve DOI
Narwedine	Live plants	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	Resolve DOI
Salsoline	Live plants	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	Resolve DOI
Sternbergine	Live plants	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	Resolve DOI
Tazettine	Bulb / clove	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	Resolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Sarikaya, Buket Bozkurt., Kaya, Gulen Irem., Onur, Mustafa Ali., Bastida, Jaume., Somer, Nehir Unver. Phytochemical investigation of Galanthus woronowii. Biochemical systematics and ecology, 2013, vol. 51, p. 276-279. DOI
Kintsurashvili, L., Vachnadze, V. Plants of the Amaryllidaceae family grown and introduced in Georgia: A source of galanthamine. Pharmaceutical chemistry journal, 2007, vol. 41, no. 9, p. 492-494. DOI
Emir, A., Somer, N.�., Kaya, G.I., Sarikaya, B., �n�r, M.A. Quality control evaluation and acetylcholinesterase inhibitory activity of Galanthus woronowii Losinsk Galanthus woronowii Losinsk.'in kalite kontrol a�i{dotless}si{dotless}ndan degerlendirilmesi ve asetilkolinesteraz inhibit�r aktivitesi . Marmara pharmaceutical journal, 2011, vol. 15, no. 2, p. 48-51. DOI
Emir, A., Polat, D. Cicek., Kaya, G. I., Sarikaya, B., Onur, M. A., Somer, N. Unver. Simultaneous Determination of Lycorine and Galanthamine in Galanthus woronowii by HPLC-DAD . Acta chromatographica, 2013, vol. 25, no. 4, p. 755-764. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature